Heparan sulfate accumulates on cell surfaces and at cell-ma-triK interfaces, and functionally modulates several of the effector molecules that support the interactions, growth, and differentiation of developing tissues. Using heparan sulfatespecific monoclonal antibodies MAb, we obtained evidence that extracts from rodent embryos contain multiple forms of cell surface-associated heparan sulfate proteoglycan (PG).
Introduction
Heparan sulfate (HS) binds and modulates the activity of matrix components, growth factors, and proteinase inhibitors, and therefore shows great potential for influencing developmental processes (2, 33) . Consistently, investigations with HS-specific antibodies have indicated that this glycosaminoglycan is expressed by a variety of embryonic tissues and that its expression correlates with specific stages of morphogenesis and development (9) . This HS forms a constituent part of many different complex glycoproteins. These heparan sulfate proteoglycans (HSPGs) form a heterogeneous group of molecules that belong to several distinct families of extracellular matrix-and cell surface-associated proteins. Some of these cellsurface PGs are membrane-spanning proteins that share similarities in domain organization and significant sequence homologies in their transmembrane and cytoplasmic parts. This family includes syndecan (syndecan-1) (35), fibroglycan (syndecan-2) (8, 28) , and at least two other transmembrane PGs (6, 11, 15, 19) . The properties and domain organizations of these membrane PGs suggest that they form part of the cell receptor repertoire for growth factors and matrix proteins, but the significance of this apparent redundancy of PGs at the cell surface is not understood.
To investigate the possibility that developmental localization may contribute functional specificity to these membrane PGs, we studied the distribution of HSPGs during tooth development. Tooth development comprises a complex series of morphogenetic processes and cell differentiations, and provides a classical paradigm for studying specific mechanisms of organogenesis in the embryo. The oral epithelium forms the tooth bud, which ultimately gives rise to the enamel organ, and the mesenchyme condenses to form the dental papilla and dental sac, which later form the odontoblasts, cementoblasts, periodontal ligaments, and alveolar bone. Reciprocal tissue interactions, including cell-cell, cell-matrix, and cell-basement membrane interactions, regulate the morphogenesis and the differentiation of the various cellular lineages involved (39,41). Molecules that show specific distributions and regulated changes of expression during tooth development and that are thought to mediate these processes include growth factors, such as EGF (epidermal growth factor) (5, 32) , NGF (nerve growth factor) (30), aFGF (acidic fibroblast growth factor) (4, 13) , bFGF (basic fibroblast growth factor) (4, 13) and TGF-p (transforming growth factor) (1, 5, 16, 17) ; extracellular matrix molecules, such as collagen, fibronectin, laminin (23,38,43), tenascin (42, 44) , and PGs (20,27); and molecules that represent potential cell surface receptors for these components (5,2230~2) . This receptor repertoire also includes the cell surface PGs, for which detailed studies on syndecan-1 suggest that this cell surface HSPG is transiently present in the enamel epithelium and in the dental mesenchyme and that this expression is regulated by epithelial-mesenchymal interactions (40, 44, 45) .
Here we investigated the distribution of HSPGs during tooth development using monoclonal antibodies (MAb) raised against the core proteins of syndecan-1 and fibroglycan (syndecan-2), antibodies against HS side chains, and by in situ hybridization. The results confirm previous data obtained for syndecan-1 and extend these studies, by indicating that fibroglycan and syndecan-1 are expressed in different structures of the tooth and by suggesting that, in addition to these two, additional, as yet unidentified cell surface HSPGs are involved in the morphogenesis and differentiation of the tooth structures.
Materials and Methods

Animals
Both golden hamster and mouse embryos were used for the initial biochemical experiments. Mouse embryos were used for immunohistochemistry, as a syndecan-1-specific antibody is available for mouse PG only. Mouse embryos were also used.for Northern analysis and for in situ hybridization.
Tissue Preparation
Mouse embryos were removed at 12, 13, 15, or 17 days of gestation (the day of the vaginal plug was taken as Day 0). The material was either frozen in 2-methylbutane Uanssen Chemicals; Geel, Belgium) pre-cooled in liquid nitrogen or fixed in 4% paraformaldehyde Uanssen Chemicals) in PBS for 3 hr at 4'C before paraffin embedding. Frozen material was cut at 8-10 pm in a cryostat. Important developmental stages of the tooth were selected from 5 -pm serial sections prepared from paraffin-embedded material. Serial sections were taken for comparison of the different antibodies.
Antibodies
The rat anti-mouse syndecan-1 antibody (MAb 281-2) was a kind gift from Dr. M. Bernfield (The Children's Hospital, Harvard Medical School, Boston, MA). The specificity of this MAb for syndecan-1 and the expression of this PG during embryonic tooth development have been reported before (40, 44, 45) . The other MAb used in this study were raised in mice and are directed against different HSPG epitopes: 10E4 against the native HS chains of the P G 3G10 against the desaturated uronic acid residues of the polysaccharide chains after heparitinase digestion of the PG'(9); and 10H4 against an epitope on the core protein of fibroglycan (8, 26) . For studies in mice, the mouse antibodies were labeled with biotin with a kit from Amersham (Amersham Belgium; Gent, Belgium). Rabbit anti-mouse HRP, rabbit anti-rat HRP and strept-ABCIHRP (streptavidin complexed with biotinylated horseradish peroxidase) (Dakopatts; Glostrup, Denmark) were used as second antibodies.
Purz3cation of Hydrophobic HSPGs
Purification of the hydrophobic HSPGs was carried out from whole hamster and mouse embryos. MAb 10E4 was used to monitor the native HSPGs, and MAb 3G10 was used to monitor the heparitinase-treated samples. The frozen embryos were homogenized with a Virsonic Cell Disrupter (Model 16-850; Virtris; Gardiner, NY) and extracted and purified as described by Lories et al. (26) . Briefly, the material was extracted in urea buffer (0.5% Triton X-100, 8 M urea, 50 mM Tris-HC1, pH 8) and submitted to ionexchange chromatography on Mono Q (Pharmacia; Uppsala, Sweden) using urea buffer with a 0-1.2 M linear NaCl gradient. Aliquots of each fraction were assayed by dot-blotting with the anti-HS chain MAb 10E4. The positive fractions were pooled, concentrated by adsorption on a Mono Q column, and step-eluted in 4 M guanidine hydrochloride (GdnHCI), 50 mM Tris-HCI, 50 mM octylglucoside, pH 8. The eluted samples were liposomeincorporated. Resulting PG-liposome mixtures were fractionated over a Sepharose CL4B column in 4 M GdnHCl buffer supplemented with protease inhibitors to separate the hydrophobic liposome-associated PGs from the non-hydrophobic PGs and free glycosaminoglycan chains. Excluded fractions yielding positive reaction with MAb 10E4 were pooled, supplemented with detergent to disrupt the liposomes, and submitted to gel filtration in 4 M GdnHCl buffer with detergent (0.5 % Triton X-100). The fractions with detergent-susceptible (hydrophobic) HSPGs, detected by MAb 10E4, were analyzed further.
EZectrophoresis and Western Blotting
Purified hydrophobic HSPGs were analyzed in Western blotting. Parts of the samples were digested with heparitinase (0.5 mlU) and chondroitinase ABC (25 mu), both separately and in combination, for 3 hr at 37°C (24). Electrophoresis of non-digested and enzyme-treated material was performed in SDS-(4416%)polyacrylamide gradient gels. Western blots on Zeta-probe nylon membranes (Bio-Rad Laboratories; Richmond, CA) were stained with the anti-HS "stub'' MAb 3G10. The reactions were detected by a chemiluminescence method in which rabbit anti-mouse Ig conjugated with alkaline phosphatase was used as second antibody.
Immunohistochemistry
An indirect immunoperoxidase staining method was used on both cryosections and paraffin sections. For staining with MAb 3G10 the sections were pre-treated with heparitinase for 2 hr at 37'C as described before (9) . All sections were incubated with PBS-1% casein for 15 min at room temperature (RT) before applying the primary antibodies. The optimal concentration of the antibodies was determined by serial dilution. The second antibodies were diluted 1:50 in PBS-1% casein. After each incubation the sections were washed three times in PBS-1% casein. For biotinylated primary MAb. 50 mM Tris-HC1 was used as wash buffer and the Strep-ABC-HRP was applied according to the instructions of the manufacturer. For control sections the primary antibodies were omitted. After the DAB reaction, 1% Os04 was used to intenslfy the staining. Finally, the sections were mounted with PBS-glycerin.
Northern Analysis
Jaws were isolated from 15-day-old mouse embryos. A total RNA sample was prepared by the acid guanidinium thiocyanate phenol-chloroform extraction method (7) . Poly(A)' mRNA was obtained through oligo (dT)cellulose chromatography. Both samples were subjected to electrophoresis in a 1.2% agarose gel containing 6% formaldehyde. The RNA was blotted on a Nytran membrane and cross-linked to the membrane by exposure to w light. The filter was pre-hybridized, hybridized, and washed as described before (10) . The probe used in Northern analysis was the same as that used for in situ hybridizations, except that the probe was radiolabeled by random oligonucleotide priming using [32P]-dCTP.
In Situ Hybridization
Preparation of Single-stranded cDNA Probes. Single-stranded cDNA probes were prepared from PCR products made using cDNA templates and com-binations of non-biotinylated insert-specific primers and biotin-SP6 or biotin-T7 primers. The sequences of the cDNA templates were confirmed by the dideoxy chain termination method. The template for making fibroglycan cDNA was a linearized pGEM-32 plasmid which comprised murine cDNA sequences that encoded only the ectodomain of fibroglycan (BP 524-958 from clone 48KM2) (8) . The resulting 48K-ECT probes were about 430 BP long. The template for making syndecan-1 cDNA was a linearized pGEM-32 plasmid with an insert that covered the whole translated region (BP 240-1173) of the mouse syndecan-1 EDNA sequence published by Saunders et al. (35) . The resulting Syn-ECT probe for in situ hybridization was about 630 BP (BP 240-869) and corresponded also to only the ectodomain of the PG. Sequences coding for the membrane-spanning and cytoplasmic domains of fibroglycan and syndecan-1 were avoided, as these domains show extensive structural homologies. After the polymerase chain reactions, the resulting double-stranded PCR products (with biotin on either the sense or anti-sense strand) were isolated by incubation with sueptavidin paramagnetic beads (Promega; Madison, WI) for 10 min at RT. After two washes with STE buffer (200 mM sodium chloride, 10 mM %is-HC1, pH 8, and 1 mM EDTA), the bound double-stranded DNA was denatured with 0.125 N NaOH for 10 min at RT and the non-biotinylated DNA strand was washed away with STE buffer. The residual biotinylated DNA strand was taken as a template for random oligonucleotide priming and the synthesis 0fcDNA labeled with [3'S]-dCTP for in situ hybridization or [32P]-dCTP for Northem analysis. The isotope-labeled Magnesphere-bound double-stranded DNA was denatured again, and a supernatant containing short isotope-labeled single-stranded sense or anti-sense cDNA probes was obtained. The singlestranded anti-sense and sense DNA probes were checked on Northem blots. Only the anti-sense probes produced signals (not shown).
Hybridization Procedure. Paraffin-embedded mouse embryos from different developmental stages were cut and mounted on poly-L-lysine-coated slides. After dewaxing, the sections were rinsed three times for 5 min in PBS and subjected to pronase treatment: 0.25 mg/ml pronase (Sigma; St Louis, MO) in 10 mM Tris-HC1, pH 7.5, 5 mM EDTA for 2 min at RT, followed by 2 mglml glycine in the same buffer for 1 min. Enzyme-treated sections were fixed in 4% paraformaldehyde in PBS for 15 min and rinsed three times with PBS. Pre-hybridization of the slides was performed in a buffer containing 50% formamide, 5 x SSC, 50 mM sodium phosphate buffer, pH 7.0.1% SDS, 10 x Denhardt's, 0.2 mg/ml heparin, 0.25 mg/ml denatured salmon sperm DNA, and 20 mM DTT. This solution was drained off after 2 hr at RT and replaced by 50 pl hybridization mixture/slide. The hybridization buffer contained 50% formamide, 0.5 M NaCI, 10% dextran sulfate, 20 mM Xis-HC1, pH 7.4, 1 mM E m , 20 mM DTT, 0.2 mglml tRNA, 1 mg/ml denatured salmon sperm DNA, and labeled probe in a concentration of 25 ng/ml. Hybridization was carried out under baked coverslips in a humid chamber for 16 hr at 42'C. Coverslips were soaked off in 2 x SSC and slides were subjected to several washes with gentle agitation: three times for 45 min at RT in 2 x SSC, 20 mM D?T, and 2 times for 2 hr at 42'C in 50% formamide, 0.6 M NaCI, 10 mM Eis-HC1, pH 7.4, 1 mM EDTA, and 20 mM DTT. The sections were dehydrated through 70% ethanol, air-dried, and coated with Kodak NTB-2 nuclear emulsion (diluted 1:l with water) at 45'C and exposed at 4'C for weeks or months in a light-sealed box. The exposed slides were developed in Kodak D19 developer for 2.5 min and fixed for 5 min. After a wash for at least 30 min in tapwater, the slides were counterstained with 0.2% toluidine blue, dehydrated through graded ethanol and xylene, and mounted in DePEX medium. The slides were viewed with darkfield or brightfield illumination.
Results
MuLt$Le Membrane -associated HSPGs in Rodent Embryos
Previous investigations in the golden hamster embryo have provided evidence that HS abounds in embryonic tissues (9) . To study the properties of the cell-surface PGs expressed by the embryo, HSPGs were Baracted from 14-day-old embryos and identifed with anti-HS MAb. The extracts were first concentrated on DEAE-Trisacryl M and further purified by ion-exchange chromatography on Mono Q using a 0-1.2-M linear NaCl gradient elution in urea buffer (Figure 1A) . The relevant fractions were traced by dot-blot testing with anti-HS "chain" MAb 10E4. To identify the membrane-associated HSPG, the positive fractions were incorporated into liposomes and further fractionated by gel filtration over Sepharose CL4B. On gel filtration in the absence of detergent, part of the 10E4-reactive material co-eluted with the liposomes in the void volume ( Figure 1B ).
On rechromatography in the presence of detergent, this Vo material shifted into the included fractions, eluting with K, = 0.3 and behaving as lipid-intercalatable HSPG ( Figure 1B) . These hydrophobic HSPGs (Vi peak) were further examined by Western blot analysis. As shown in Figure 2 . immunoblotting with the anti-HS "stub" MAb 3G10 yielded several bands in the heparitinase-treated sample: two strong bands at 64 KD and 48 KD and two moderately stained bands around 125 KD and 36 KD; a doubly heparitinase and chondroitinase ABC-digested lane showed one additional faint band around 80 KD (Figure 2 ). This result was similar to prior results obtained with cultured fetal human lung fibroblasts (24), and indicated the presence of at least five core proteins in the cell-surface HSPG fraction in hamster embryos. Materials extracted from mouse or hamster embryos yielded similar results (not shown). clearly demonstrating the presence of multiple cellsurface HSPG species in embryonic tissues.
To further analyze the significance of this PG redundancy, we performed an in situ study of the expression of cell surface-associated HS during the development of the tooth in the mouse embryo. This choice was inspired by the availability, in addition to "nondiscriminating" anti-HS antibodies, of specific MAb and cDNA probes for two of these cell-surface PGs (i.e., syndecan-1 and fibroglycan) in the mouse (8, 35 ) and because of the extensive evidence for the developmental regulation of syndecan-1 in these embryonic tissues (40,44,45).
Expression of Hepurun Sulfate
In a first approach, the expression of HS in the tooth was examined with MAb 10E4. the antibody that reacts specifically with an epitope in native HS chains. MAb 10E4 stained the enamel epithelium and its derivatives, the dental basement membrane and the dental mesenchyme. However, specific changes and spatial differences in HS expression were seen throughout tooth development and were closely associated with the process of morphogenesis and cytodifferentiation. On sagittal sections of Day 12 mice, distinct 10E4 staining was found in the invaginating epithelial bud of the incisor and in the nearby oral epithelial cells, whereas the more distant oral epithelial cells were virtually unstained ( Figures 3A and  4A) . At that time, a thick layer of mesenchyme underneath the oral epithelium showed intense stain ( Figures 3A and 4A) . With further development of the epithelial bud, the epithelial staining was mostly restricted to the layer of cells in the bud that occurred in close apposition to the mesenchyme (Figures 3B and 4D) . The reaction in the mesenchyme became even more intense but gradually confined to the periepithelial mesenchyme ( Figures 3B and  4D ). During the cap stage, around Day 13 to 15, the most striking changes in 10E4 epitope distribution occurred in the dental mesenchyme. The reactivity in the dental papilla was originally nearly as strong as in the dental sac ( Figure 3C ) but, from late cap stage on, it decreased gradually from mesial towards distal ( Figures 3D  and 4G ). In the dental sac, the mesenchymal cells that surrounded the outer layer of enamel epithelium were strongly stained. However, this mesenchyme showed an asymmetric staining pattern: the posterior or lingual side stained more strongly than the anterior or labial side, both in the incisor (Figures 3C, 3D , and 4G) and in the molar (not shown), and the asymmetric staining persisted until late bell stage. During the bell stage, expression of the 10E4 epitope persisted and even transiently intensified on both the inner and outer layers of the enamel organ ( Figure 3E ). Ultimately, at late bell stage, the staining decreased in the inner layer. Meanwhile, the stratum intermedium and, less extensively, the stellate reticulum of the enamel organ acquired some 10E4 reactivity. In the dental papilla, the differentiating odontoblasts became 10E4positive, with their stain mostly concentrated on the cell surface facing the basement membrane (see Figures 5A, and 5B) . The staining in the dental sac mesenchyme remained intense. Throughout all developmental stages, MAb 10E4 also reacted with the basement membrane of the enamel epithelium. MAb 3G10, directed against the desaturated uronates that terminate the HS "stubs" of heparitinase-digested HSPG. as expected, stained all areas positive for MAb 10E4. It was different from 10E4 in that it stained additional areas, such as the oral epithelium, and in that no asymmetry in the staining of dental sac mesenchyme could be visualized (compare Figures 3D and 3F) . Almost no staining is seen on the more distant oral epithelium. (E) At late bud stage, staining is confined to one layer of the enamel epithelium and to the dental mesenchyme. (C) At early cap stage, the enamel epithelium is still positive. The staining in the mesenchyme of the dental papilla and dental sac is strong. (D) At late cap stage the staining in the dental papilla is decreased from the mesial towards the distal parts of the cuspal region. The mesenchyme of the dental sac shows an asymmetric reaction. The basement membrane of the enamel epithelium is stained. (E) At bell stage, the inner and outer enamel epithelium maintains its reaction and the stratum intermedium acquires staining. The dental sac is still positive and the differentiating odontoblasts are stained. (F) A section consecutive to D (late cap stage) stained with MAb 3G10 shows no asymmetry in the dental sac, and a positive oral epithelium. oe, oral epithelium; tb, tooth bud; m, mesenchyme; dm, dental mesenchyme; de, dental enamel; dp, dental papilla, ds, dental sac; si. stratum intermedium; st, stellate reticulum; am, pre-ameloblasts; a, anterior; p, posterior. Bars = 100 pm. The dental sac mesenchyme shows asymmetric staining for the three MAb at the cap stage: the 10E4 and 10H4 stainings are stronger at the posterior (lingual) side in Contrast to 281-2 staining. which was found at the anterior (labial) side (compare G.H, and I). oe, oral epithelium; 4, tooth bud; m, mesenchyme; dm, dental mesenchyme; de. dental enamel epithelium; dp, dental papilla: ds. dental sac; f, lip furrow; a, anterior; p, posterior. Bar = 100 pm. mesenchyme ( Figure 4B ). The staining condensed in the dental mesenchyme at late bud stage ( Figure 4E ). From the cap stage on, the 10H4 staining was limited to the dental sac and the surrounding mesenchyme, leaving the dental papilla unstained ( Figure 4H) . As with the anti-HS MAb 10E4 ( Figure 4G ), the staining of 10H4 was asymmetric and more intense on the posterior side, but unlike
P
Expression of the Core Proteins of Fibrogl'ycan and Syndecan-1
MAb 10H4, which reacts with an epitope of the core protein of fibroglycan, stained the dental mesenchyme, whereas the dental epithelium and its derivatives remained unreactive. At the initial bud stage, the 10H4 epitope was diffusely expressed by the jaw 10E4 it was most pronounced in the outer layers of the sac ( Figure  4H ). At late bell stage, the differentiating odontoblasts in the dental papilla started to express the 10H4 epitope at their "apical" surface and also in the presumed pre-dentin. The supporting tissue and the alveolar bone continued to express the 10H4 epitope ( Figures  5E and 5F) . The distribution of syndecan-1 detected by MAb 281-2 was only partly overlapping with the distribution of the 10E4 HS epitope and was distinct from that of fibroglycan. Syndecan-1 was expressed on the oral epithelium and temporarily on the epithelial cells of the budding tooth ( Figures 4C. 4F and 41) . It was not detectable in pre-ameloblasts ( Figure 5D ), but these cells remained positive for the 10E4 epitope until late bell stage ( Figure 5B ). However, the other enamel organ structures, the stratum intermedium and the stellate reticulum, showed weak or moderate staining for MAb 281-2 ( Figures 5C and 5D ). In the dental mesenchyme, syndecan-1 expression was more restricted and less persistent than the 10E4 epitope. In the early cap stage the 281-2 epitope was mainly restricted to some parts of the dental mesenchyme, whereas the 10E4 epitope was widely spread over the dental mesenchyme and also the surrounding jaw mesenchyme (Figures 4G and 41) . The 281-2 staining lasted in the dental papilla only up to thecap stage, and later also disappeared from the dental sac ( Figures 5C and 5D ), whereas the 10E4 epitope continued to be expressed in these areas, particularly in the differentiating odontoblasts ( Figures 5A and 5B) . Interestingly, at the cap stage and early bell stage, syndecan-1 also showed an asymmetric distribution in the dental sac mesenchyme. However, the distribution of syndecan-1 (Figure 41) formed almost a mirror image of that obtained for the HS epitope 10E4 ( Figure   4G ) and of that of fibroglycan (Figure 4H) . Indeed, 281-2 stained the tissues more intensely at the labial side of the tooth germ, both in the incisor and in the molar (Figure 41) .
Expression of the Messages for Fibroglycan and Syndecan-1
These non-overlapping distributions were further investigated at the level of the corresponding transcripts. First, the expression of mRNA for fibroglycan and syndecan-1 in mouse embryonic jaws was examined by Northern blot analysis. As shown in Figure 6 , the messages for murine fibroglycan had sizes of 1.2, 2.3, and 3.5 KB. The transcripts of 1.2 and 3.5 KB were produced in higher amounts than the 2.3 KB message. The mouse syndecan-1 probe detected two signals of 3.4 and 2.6 KB in embryonic jaw, with the 2.6 KB transcript having a much higher expression than the 3.4 KB product.
The in situ distribution of the transcripts for fibroglycan and syndecan-1 was then analyzed on tissue sections. Both were present in the embryonic tooth structure (Figure 7) . At the bud stage, the syndecan-1 signal was found in the bud epithelium but was much stronger in the surrounding dental mesenchyme (Figure 7A) . At the cap stage, the dental sac mesenchyme showed higher levels of syndecan-1 transcripts than the dental papilla ( Figure  7D) . At both stages, the syndecan-1 signal was more pronounced at the anterior or labial side of the dental mesenchyme than at the posterior or lingual side (Figures 7A and 7D) . At the early bell stage (Figure 7G) , the syndecan-1 signal had almost disappeared from the enamel epithelium, and in the dental mesenchyme the signal was more pronounced in the distal region of the papilla and in the dental sac. The fibroglycan signal, on the other hand, was detectable only in the dental mesenchyme ( Figures 7B. 7E, and 7H) . At the late bud stage, and in contrast to what was obtained for syndecan-1, the signal for fibroglycan was more intense on the lingual than on the labial side of the mesenchyme (Figure 7B ). At the bell stage, and as observed for the fibroglycan core protein, the messages of fibroglycan were also found in the differentiating odontoblasts ( Figure 7H ). In addition, there was a clear signal for fibroglycan in the pre-osteogenic condensing mesenchyme that formed the maxillary bone structure ( Figures 7B and 7E) , whereas no syndecan-1 could be detected at these sires ( Figures 7A and 7D) . Therefore, the asymmetric distributions seen for the core proteins seemed in accordance with the distributions of the transcripts, ruling out possible masking effects.
Discussion
Because of their strategic positions on the cell surface and of their functional versatility, with their capacities for multiple interactions with other molecules, cell surface HSPGs seem well-endowed to play major roles in the control of development. Consistently, the present study on the embryonic tooth, taken as a paradigm for the morphogenesis and differentiation of embryonic tissues, has provided evidence that several types of HSPG are expressed during development. HSPGs were found in both the enamel organ and the dental mesenchyme. Their expression showed stage-specific restrictions, with temporal and spatial changes that accorded with the morphogenetic and histogenetic events that characterize the development of the tooth. Moreover, syndecan-1 and fibroglycan, two distinct members of a specific family of cell-surface PGs, had unique expression patterns at both the transcriptional and the protein level, implying distinct individual biological functions for the different HSPGs in (tooth) development.
Heterogeneity of the Cell-Surface HSPGs in the Embryo
The immunochemical experiments with MAb 10E4 and 3G10 on the extracts from hamster and mouse embryos provided clear evidence for the concomitant expression of multiple cell-surface HSPGs during development. The results are consistent with the molecular cloning during the past few years of several different transmembrane (6, 11, 15, 19, 28, 35) and glypiated (IO) proteoglycan forms (including some from embryonic sources), and are highly reminiscent of the structural heterogeneity of the cell surface HSPGs in cultured human cell lines (25, 26) . The results in the hamster em- in the distal region of the dental papilla and in the surrounding dental sac mesenchyme. (E) The fibroglycan signal was intense in the condensing dental mesenchyme at the bud stage. (E) Later it was more limited to the dental sac and weak in the dental papilla. (H) At the bell stage, the fibroglycan signal occurred in the differentiating odontoblasts and in the outer part of dental sac. The pre-osteogenic condensing mesenchyme in the maxilla also showed strong signal for fibroglycan @.E) but was negative for syndecan-1 (AD). de, dental enamel epithelium; dm, dental mesenchyme; ds. dental sac; dp, dental papilla; bm, boneforming mesenchyme; am, pre-ameloblasts; od, differentiating odontoblasts; a, anterior; p, posterior. Bars: = 100 pm. bryo, with a prominent band at 48 KD, were more similar to the results obtained from human lung fibroblasts than to those obtained in human mammary epithelial cells (25), which may indicate that in the embryo non-epithelial cells contribute in large part to the composition of the cell-surface PG fraction. This would be consistent with the immunohistochemical findings reported here and with prior morphological analyses with these HS-specific antibodies in the embryo (9) .
Expression of Cell-Surface HSPG in the Enamel Organ
Syndecan-1 was the only cell surface HSPG that had been identified so far in the dental epithelium. It was shown to be transiently present in the enamel epithelium at the bud stage, to be remarkably reduced later, and to reappear at the bell stage in the stratum intermedium and the stellate reticulum (40,45). These findings were confirmed in the present study, but clearly this epithelial expression of syndecan-1 only partly fitted the results obtained with MAb 1OE4, the antibody that reacts with HS, despite attempts to unmask possible additional syndecan-1 epitopes by heparitinase, chondroitinase, and collagenase treatments (results not shown). Unlike syndecan-1, cell surface HSPG(s), as detected by the anti-HS MAb 10E4 (of by the anti "stub" MAb 3G10), were expressed in the enamel organ throughout tooth development. Persistence of 10E4 staining on the epithelial cell surface combined with a decrease in syndecan-l staining could be due to two possibilities. One is that syndecan-1 in the enamel epithelium could have different structures at different developmental stages. Indeed, syndecan-1 has been shown to be polymorphic in epithelial cells, owing to changes in its glycosaminoglycan chains, and this polymorphism depended on the type of the epithelial cell (34) and also on the stage of differentiation of a specific epithelial cell (3) . In this case, a maintained 10E4 staining may be explained by an increase of the 10E4-epitope, either as a change in the number, structure, or the length of the HS chains on syndecan-1, even if the syndecan-1 core protein were reduced. A second possibility implies that other cell surface HSPG(s), different from syndecan-1 (but not fibroglycan; see below) may be expressed along with syndecan-1. In any case the data ultimately suggest that syndecan-1 is lost with the initiation of ameloblast differentiation when another cell-surface HSPG, detected here by 1OE4, is expressed. The epithelial expression of two different cell-surface HSPGs at different developmental stages suggests that these may play different roles in epithelial development.
HSPG Heterogeneity in the Dental Mesenchyme
The combined data obtained from the anti-HS MAb and from the anti-core protein MAb and the in situ hybridization analysis indicated that in the dental mesenchymal cells, several different types of HSPG were also present and that their expressions were selective and stage-specific.
Fibroglycan was mainly expressed by the mesenchymal cells associated with the formation of hard tissue. Syndecan-1 was temporarily present in the papilla and in the dental sac. Areas in the dental papilla that were negative for syndecan-1 and for fibrogly-can, in which the 10E4 staining persisted up to late bell stage, suggested the presence of an additional type(s) of HSPG in the dental papilla. Moreover, the individual composition of the HS chains appears to be different from one PG molecule to another or from one part of the tooth to another. This is indicated by some discrepancies between MAb 10E4, which traces the mass of HS expressed, and MAb 3G10, which (after heparitinase) traces the (remains of the) chains that were initiated on the cores (Figures 3D  and 3F ). The asymmetric stainings and mirror images in the dental sac mesenchyme obtained for lOE4 antigen vs syndecan-1 ( Figures  4G and 41) , for example, could be due to the presence of more 10E4 epitope in the HS chains at the posterior side rather than to the presence of more chains, since no asymmetric distribution was seen with 3G10. On the other hand, it can also be noted that the alveolar bone expressed the 10H4 epitope but few HS epitopes. It is possible that in bone the core protein of fibroglycan is present but with less or unavailable HS epitope. This suggests a polymorphic structure of fibroglycan depending on tissue types, similar to what has been observed for syndecan-1 in epithelia (34). At a minimum, the results in the mesenchyme again indicate the expression of multiple forms, if not species, of PG during development.
Fibroglycan and the Fomation of Hard Tissue
In contrast to what was found for syndecan-1, the highest amounts of fibroglycan did not appear at the bud and cap stages, which are dominated by the morphogenesis of the enamel organ (39), but rather at the bell stage, when the mesenchymal cells undergo cytodifferentiation (38). Strong staining was restricted to the dental sac mesenchyme, and later to the alveolar bone and the differentiating odontoblasts ( Figures 4B, 4E, 4H, 5E, and 5F ). This selective expression might be an indication that fibroglycan participates in the terminal differentiation of mesenchymal cells that are committed to the formation of connective and hard tissue, i.e., odontoblasts in the tooth and osteoblasts in the alveolar bone. The expression of HS epitopes and of fibroglycan in areas ofchondrogenesis elsewhere in the embryo (8) further suggests that this HSPG functions in processes of chondrogenesis and osteogenesis. Syndecan-1, in contrast, was absent from those tissues in the tooth, and has even been suggested to prevent the onset of chondrogenesis in limb development (37).
How and why fibroglycan, rather than syndecan-1, might contribute to the development of hard tissues remains uncertain. Growth factor TGFP and related bone morphogenetic proteins are presumed to play an important role in chondrogenesis, osteogenesis, and odontogenesis. This contention is based on the expression patterns of these cytokines in the embryonic tissues (5, 17) , their effects on osteoblast phenotypic markers (18, 31) , and on the observation that a TGFP-like molecule in combination with another component present in dentin extracts promotes odontogenesis in dental papillae cultured in vitro (1) . Fibroglycan, which is present in differentiating odontoblasts at late bell stage, might also be induced by TGF-P (but thus far no evidence for regulation by this cytokine was obtained) or, alternatively, might bind and modulate or assist in the effects of this factor (29). On the other hand, it is also known that bFGF is expressed at the time of odonotoblast differentiation (4, 13) and that HSPG can bind and modulate the ac-tivity of bFGF and of several other heparin-binding growth factors that are stored in an extracellular matrix-bound form (12,14) . A preferential concentration of bFGF occurs also in the condensed dental mesenchyme and mostly in the posterior and cervical parts of the tooth germs (4). which is reminiscent of a similar concentration of fibroglycan and 10E4 epitope (HS chains) in these posterior parts. Our own unpublished investigations have identified fibroglycan as a potential cell-surface receptor and modulator of bFGF. Hence, HSPG, in casu fibroglycan, might mobilize bFGF from the basement membrane and mesenchymal matrix, and by doing so could regulate the action of bFGF on odontoblast and bone differentiation. The situation may be analogous to that in vertebrate limb development, where the balance between members of the TGRS and FGF superfamilies is thought to form part of the inductive intercellular signaling system that controls limb morphogenesis (21). Alternatively, specific distributions have also been found for collagen Type I in odontoblasts and in osteoblasts of alveolar bone (36), whereby collagen Type I was considered as a marker for odontoblast and osteoblast differentiation. Moreover, a membrane protein that interacts with the carboxyl-terminal extension of the collagen-binding domain offibronectin has recently also been implicated in odontoblast differentiation (22). Since we also identified fibroglycan as a collagen Type Iand fibronectin-binding PG (unpublished results), a possible role for fibroglycan as a matrix receptor essential for mesenchymal cell differentiation should also be considered.
In summary, the specific distributions and the reIliarkable changes in the expression of cell surface-associated heparan sulfate and of the core proteins of two cell surface HSPGs in mbryonic tooth suggest important and specific but yet to be defined functions for the different cell-surface HSPGs in development.
